10-K Decoder · All companies

Climb Bio, Inc.

CLYM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$67.9M−$82.0M+17.2%
Net income−$59.9M−$73.9M+19.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$16.9M−$14.9M−13.4%
Net income−$14.6M−$12.9M−13.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Climb Bio's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Climb Bio profitable in FY2025?
No: net income was −$59.9M and operating income −$67.9M in FY2025.
What was Climb Bio's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.